Zheng Q, Wang D, Lin R, Lv Q, Wang W
Front Immunol. 2022; 13:1013322.
PMID: 36189314
PMC: 9520788.
DOI: 10.3389/fimmu.2022.1013322.
Bjornsson A, Palsson O, Kristjansson M, Gunnarsson P, Grondal G, Gudbjornsson B
ACR Open Rheumatol. 2021; 4(2):187-194.
PMID: 34842362
PMC: 8843757.
DOI: 10.1002/acr2.11382.
Murray K, Low C, ORourke A, Young F, Callanan I, Feeney E
Clin Rheumatol. 2019; 39(3):747-754.
PMID: 31820135
DOI: 10.1007/s10067-019-04841-6.
Dieperink S, Glintborg B, Oestergaard L, Norgaard M, Benfield T, Mehnert F
BMJ Open. 2019; 9(9):e030999.
PMID: 31481566
PMC: 6731901.
DOI: 10.1136/bmjopen-2019-030999.
Gutierrez M, Desiderio S, Wang N, Darrah E, Cappelli L, Nino G
J Immunol Res. 2019; 2019:3658215.
PMID: 31183387
PMC: 6512050.
DOI: 10.1155/2019/3658215.
Clinical characteristics and prognostic factors of pneumonia in patients with and without rheumatoid arthritis.
Wakabayashi A, Ishiguro T, Takaku Y, Miyahara Y, Kagiyama N, Takayanagi N
PLoS One. 2018; 13(8):e0201799.
PMID: 30075013
PMC: 6075779.
DOI: 10.1371/journal.pone.0201799.
B Lymphocytes in Rheumatoid Arthritis and the Effects of Anti-TNF-α Agents on B Lymphocytes: A Review of the Literature.
Pala O, Diaz A, Blomberg B, Frasca D
Clin Ther. 2018; 40(6):1034-1045.
PMID: 29801753
PMC: 6792291.
DOI: 10.1016/j.clinthera.2018.04.016.
Incidence and Risk Factors for Infections Requiring Hospitalization, Including Pneumocystis Pneumonia, in Japanese Patients with Rheumatoid Arthritis.
Hashimoto A, Suto S, Horie K, Fukuda H, Nogi S, Iwata K
Int J Rheumatol. 2017; 2017:6730812.
PMID: 29181029
PMC: 5664349.
DOI: 10.1155/2017/6730812.
Mycobacterium chelonae hand infection after steroid injection in a patient with rheumatoid arthritis receiving long-term linezolid therapy.
Olesen J, Wang M, Wejse C
BMJ Case Rep. 2017; 2017.
PMID: 28137898
PMC: 5293961.
DOI: 10.1136/bcr-2016-217257.
Nontuberculous mycobacterial infection in rheumatoid arthritis patients: a single-center experience in South Korea.
Lim D, Kim Y, Shim T, Jo K, Ghang B, Ahn S
Korean J Intern Med. 2017; 32(6):1090-1097.
PMID: 28063416
PMC: 5668388.
DOI: 10.3904/kjim.2015.357.
Advances in the treatment of cervical rheumatoid: Less surgery and less morbidity.
Mallory G, Halasz S, Clarke M
World J Orthop. 2014; 5(3):292-303.
PMID: 25035832
PMC: 4095022.
DOI: 10.5312/wjo.v5.i3.292.
Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-α antagonists.
Germano V, Cattaruzza M, Osborn J, Tarantino A, Di Rosa R, Salemi S
J Transl Med. 2014; 12:77.
PMID: 24655394
PMC: 3994399.
DOI: 10.1186/1479-5876-12-77.
Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy.
Winthrop K, Iseman M
Nat Rev Rheumatol. 2013; 9(9):524-31.
PMID: 23797309
DOI: 10.1038/nrrheum.2013.82.
Trends in serious infections in rheumatoid arthritis.
Ni Mhuircheartaigh O, Matteson E, Green A, Crowson C
J Rheumatol. 2013; 40(5):611-6.
PMID: 23547208
PMC: 3885897.
DOI: 10.3899/jrheum.121075.
Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study.
Blumentals W, Arreglado A, Napalkov P, Toovey S
BMC Musculoskelet Disord. 2012; 13:158.
PMID: 22925480
PMC: 3495205.
DOI: 10.1186/1471-2474-13-158.
Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective.
De Keyser F
Curr Rheumatol Rev. 2011; 7(1):77-87.
PMID: 22081766
PMC: 3182090.
DOI: 10.2174/157339711794474620.
Safety of biologic therapy in rheumatoid arthritis.
Woodrick R, Ruderman E
Nat Rev Rheumatol. 2011; 7(11):639-52.
PMID: 21989284
DOI: 10.1038/nrrheum.2011.145.
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with....
Galloway J, Hyrich K, Mercer L, Dixon W, Fu B, Ustianowski A
Rheumatology (Oxford). 2010; 50(1):124-31.
PMID: 20675706
PMC: 3105607.
DOI: 10.1093/rheumatology/keq242.
Vaccinations in patients with immune-mediated inflammatory diseases.
Rahier J, Moutschen M, Van Gompel A, Van Ranst M, Louis E, Segaert S
Rheumatology (Oxford). 2010; 49(10):1815-27.
PMID: 20591834
PMC: 2936949.
DOI: 10.1093/rheumatology/keq183.
Assessing infection risk with biologic agents in RA: methodological challenges.
Fisher M, Greenberg J
Nat Rev Rheumatol. 2009; 5(5):288-91.
PMID: 19412196
DOI: 10.1038/nrrheum.2009.51.
